Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
S Araki, M Ohori, M Yugami - Frontiers in Oncology, 2023 - frontiersin.org
Accumulating evidence has indicated that pre-mRNA splicing plays critical roles in a variety
of physiological processes, including development of multiple diseases. In particular …
of physiological processes, including development of multiple diseases. In particular …
[HTML][HTML] Cancer stem cells and androgen receptor signaling: partners in disease progression
JC Quintero, NF Díaz, M Rodríguez-Dorantes… - International journal of …, 2023 - mdpi.com
Cancer stem cells exhibit self-renewal, tumorigenesis, and a high differentiation potential.
These cells have been detected in every type of cancer, and different signaling pathways …
These cells have been detected in every type of cancer, and different signaling pathways …
[HTML][HTML] Androgen receptors and sociosexual behaviors in mammals: the limits of generalization
A Ågmo - Neuroscience & Biobehavioral Reviews, 2024 - Elsevier
Circulating testosterone is easily aromatized to estradiol and reduced to dihydrotestosterone
in target tissues and elsewhere in the body. Thus, the actions of testosterone can be …
in target tissues and elsewhere in the body. Thus, the actions of testosterone can be …
Role of the androgen receptor in gender-related cancers
E Sabbatino, V Tutino, F Licitra, M Di Donato… - Endocrines, 2023 - mdpi.com
The androgen receptor (AR) is expressed in many cell types, and its related signaling is
widely investigated in hormone-dependent cancers such as prostate and breast. The …
widely investigated in hormone-dependent cancers such as prostate and breast. The …
MYC and p53 alterations cooperate through VEGF signaling to repress cytotoxic T cell and immunotherapy responses in prostate cancer
KC Murphy, KD DeMarco, L Zhou, Y Lopez-Diaz… - …, 2024 - pmc.ncbi.nlm.nih.gov
Patients with castration-resistant prostate cancer (CRPC) are generally unresponsive to
tumor targeted and immunotherapies. Whether genetic alterations acquired during the …
tumor targeted and immunotherapies. Whether genetic alterations acquired during the …